Cochrane Abstracts
Naloxone for opioid‐exposed newborn infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naloxone for Opioid‐exposed Newborn Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439725/all/Naloxone_for_opioid‐exposed_newborn_infants.
Naloxone for opioid‐exposed newborn infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439725/all/Naloxone_for_opioid‐exposed_newborn_infants. Accessed March 24, 2025.
Naloxone for opioid‐exposed newborn infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439725/all/Naloxone_for_opioid‐exposed_newborn_infants
Naloxone for Opioid‐exposed Newborn Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439725/all/Naloxone_for_opioid‐exposed_newborn_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naloxone for opioid‐exposed newborn infants
ID - 439725
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439725/all/Naloxone_for_opioid‐exposed_newborn_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
